Login to Your Account

UK Project Lays Groundwork For NHS-Targeted Drug Adoption

By Nuala Moran
BioWorld International Correspondent

Wednesday, November 30, 2011
LONDON – The first patients have been enrolled in a ₤5.5 million (US$8.5 million) project that aims to provide the foundation stone of a single nationwide system for tumor gene testing to enable rapid adoption of targeted cancer drugs.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription